MCPH1 inhibits condensin II during interphase by regulating its SMC2-kleisin interface
- University of Oxford, United Kingdom
- The Institute of Cancer Research, United Kingdom
- Baylor College of Medicine, United States
- Human Technopole, Italy
Abstract
The dramatic change in morphology of chromosomal DNAs between interphase and mitosis is one of the defining features of the eukaryotic cell cycle. Two types of enzymes, namely cohesin and condensin confer the topology of chromosomal DNA by extruding DNA loops. While condensin normally configures chromosomes exclusively during mitosis, cohesin does so during interphase. The processivity of cohesin’s loop extrusion during interphase is limited by a regulatory factor called WAPL, which induces cohesin to dissociate from chromosomes via a mechanism that requires dissociation of its kleisin from the neck of SMC3. We show here that a related mechanism may be responsible for blocking condensin II from acting during interphase. Cells derived from patients affected by microcephaly caused by mutations in the MCPH1 gene undergo premature chromosome condensation but it has never been established for certain whether MCPH1 regulates condensin II directly. We show that deletion of Mcph1 in mouse embryonic stem cells unleashes an activity of condensin II that triggers formation of compact chromosomes in G1 and G2 phases, which is accompanied by enhanced mixing of A and B chromatin compartments, and that this occurs even in the absence of CDK1 activity. Crucially, inhibition of condensin II by MCPH1 depends on the binding of a short linear motif within MCPH1 to condensin II's NCAPG2 subunit. We show that the activities of both Cohesin and Condensin II may be restricted during interphase by similar types of mechanisms as MCPH1's ability to block condensin II's association with chromatin is abrogated by the fusion of SMC2 with NCAPH2. Remarkably, in the absence of both WAPL and MCPH1, cohesin and condensin II transform chromosomal DNAs of G2 cells into chromosomes with a solenoidal axis showing that both cohesin and condensin must be tightly regulated to adjust the structure of chromatids for their successful segregation.
Data availability
HiC sequencing data has been deposited in GEO. (accession number: GSE188988)
-
MCPH1 inhibits condensin II during interphase by regulating its SMC2-kleisin interfaceNCBI Gene Expression Omnibus, GSE188988.
Article and author information
Author details
Lothar Schermelleh
Alessandro Vannini
Funding
Wellcome Trust (107935/Z/15/Z)
- Martin Houlard
- Jonathan Godwin
- Kim Nasmyth
McNair Medical Institute Scholar Award
- Muhammad S Shamim
- David Weisz
- Aviva Presser Aiden
- Erez Lieberman-Aiden
NIH Encyclopedia of DNA Elements Mapping Center Award (UM1HG009375)
- Muhammad S Shamim
- David Weisz
- Aviva Presser Aiden
- Erez Lieberman-Aiden
US-Israel Binational Science Foundation Award (2019276)
- Muhammad S Shamim
- David Weisz
- Aviva Presser Aiden
- Erez Lieberman-Aiden
Behavioral Plasticity Research Institute (NSF DBI-2021795)
- Muhammad S Shamim
- David Weisz
- Aviva Presser Aiden
- Erez Lieberman-Aiden
NSF Physics Frontiers Center Award (NSF PHY-2019745)
- Muhammad S Shamim
- Aviva Presser Aiden
- Erez Lieberman-Aiden
- Lothar Schermelleh
NIH CEGS Award (RM1HG011016-01A1)
- Muhammad S Shamim
- David Weisz
- Aviva Presser Aiden
- Erez Lieberman-Aiden
European Research Council (294401)
- Martin Houlard
- Jonathan Godwin
- Kim Nasmyth
Cancer Research UK (26747)
- Martin Houlard
- Jonathan Godwin
- Kim Nasmyth
Wellcome Trust (107457/Z/15/Z)
- Lothar Schermelleh
Wellcome Trust (091911)
- Lothar Schermelleh
Paul and Daisy Soros Foundation
- Muhammad S Shamim
Cancer Research UK (CR-UK C47547/A21536)
- Erin E Cutts
- Alessandro Vannini
Wellcome Trust (200818/Z/16/Z)
- Erin E Cutts
- Alessandro Vannini
Welch Foundation (Q-1866)
- Muhammad S Shamim
- David Weisz
- Aviva Presser Aiden
- Erez Lieberman-Aiden
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#08-133) of the University of Arizona. The protocol was approved by the Committee on the Ethics of Animal Experiments of the University of Minnesota (Permit Number: 27-2956). All surgery was performed under sodium pentobarbital anesthesia, and every effort was made to minimize suffering.
Copyright
© 2021, Houlard et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,839
- views
-
- 415
- downloads
-
- 30
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
MCPH1 inhibits condensin II during interphase by regulating its SMC2-kleisin interface
eLife 10:e73348.
https://doi.org/10.7554/eLife.73348
Further reading
-
- Biochemistry and Chemical Biology
The development of proteolysis targeting chimeras (PROTACs), which induce the degradation of target proteins by bringing them into proximity with cellular E3 ubiquitin ligases, has revolutionized drug development. While the human genome encodes more than 600 different E3 ligases, current PROTACs use only a handful of them, drastically limiting their full potential. Furthermore, many PROTAC development campaigns fail because the selected E3 ligase candidates are unable to induce degradation of the particular target of interest. As more and more ligands for novel E3 ligases are discovered, the chemical effort to identify the best E3 ligase for a given target is exploding. Therefore, a genetic system to identify degradation-causing E3 ligases and suitable target/E3 ligase pairs is urgently needed. Here, we used the well-established dimerization of the FKBP12 protein and FRB domain by rapamycin to bring the target protein WDR5 into proximity with candidate E3 ligases. Strikingly, this rapamycin-induced proximity assay (RiPA) revealed that VHL, but not Cereblon, is able to induce WDR5 degradation - a finding previously made by PROTACs, demonstrating its predictive power. By optimizing the steric arrangement of all components and fusing the target protein with a minimal luciferase, RiPA can identify the ideal E3 for any target protein of interest in living cells, significantly reducing and focusing the chemical effort in the early stages of PROTAC development.
-
- Biochemistry and Chemical Biology
- Microbiology and Infectious Disease
The cell wall of human fungal pathogens plays critical roles as an architectural scaffold and as a target and modulator of the host immune response. Although the cell wall of the pathogenic yeast Candida albicans is intensively studied, one of the major fibrillar components in its cell wall, β-1,6-glucan, has been largely neglected. Here, we show that β-1,6-glucan is essential for bilayered cell wall organization, cell wall integrity, and filamentous growth. For the first time, we show that β-1,6-glucan production compensates the defect in mannan elongation in the outer layer of the cell wall. In addition, β-1,6-glucan dynamics are also coordinated by host environmental stimuli and stresses with wall remodeling, where the regulation of β-1,6-glucan structure and chain length is a crucial process. As we point out that β-1,6-glucan is exposed at the yeast surface and modulate immune response, β-1,6-glucan must be considered a key factor in host–pathogen interactions.
